Principles of peripheral blood mononuclear cell apheresis in a preclinical canine model of hematopoietic cell transplantation

Journal of Veterinary Internal Medicine

Volumn 22, Issue 1, 2008, Pages 74-82

  Lupu, M ^a,b   Gooley, T ^a,c   Zellmer, E ^a   Graves, S S ^a   Storb, R ^a,d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Automated blood separator; Central venous dual lumen catheter; Dog; Hematopoietic stem cell collection; Outcomes; Peripheral blood stem cell mobilization.

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 40549099040     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2007.0016.x     Document Type: Article

References (68)

1. 1 Lupu M, Storb R. Five decades of progress in haematopoietic cell transplantation based on preclinical canine model (Review). Vet Compar Oncol 2007 ; 5: 14–30.
2. 2 Deeg HJ, Storb R. Bone marrow transplantation in dogs. In: Makowka L, Cramer DV, Podesta LG, eds. Handbook of Animal Models in Transplantation Research. Boca Raton, FL: CRC Press Inc ; 1994: 255–285.
3. 3 Storb R, Epstein RB, Bryant J, et al. Marrow grafts by combined marrow and leukocyte infusions in unrelated dogs selected by histocompatibility typing. Transplantation 1968 ; 6: 587–593.
4. 4 Abrams RA, McCormack K, Bowles C, Deisseroth AB. Cyclophosphamide treatment expands the circulating hematopoietic stem cell pool in dogs. J Clin Invest 1981 ; 67: 1392–1399.
5. 5 De Revel T, Appelbaum FR, Storb R, et al. Effects of granulocyte colony stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 1994 ; 83: 3795–3799.
6. 6 Nash RA, Schuening FG, Seidel K, et al. Effect of recombinant canine granulocyte‐macrophage colony‐stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood 1994 ; 83: 1963–1970.
7. 7 Sandmaier BM, Storb R, Santos EB, et al. Allogeneic transplants of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors. Blood 1996 ; 87: 3508–3513.
8. 8 Burroughs L, Mielcarek M, Little M‐T, et al. Durable engraftment of AMD3100‐mobilized autologous and allogeneic peripheral blood mononuclear cells in a canine transplantation model. Blood 2005 ; 106: 4002–4008.
9. 9 Cavins JA, Kasakura S, Thomas ED, Ferrebee JW. Recovery of lethally irradiated dogs following infusion of autologous marrow stored at low temperature in dimethyl‐sulphoxide. Blood 1962 ; 20: 730–734.
10. 10 Cavins JA, Scheer SC, Thomas ED, Ferrebee JW. The recovery of lethally irradiated dogs given infusions of autologous leukocytes preserved at −80 C. Blood 1964 ; 23: 38–43.
11. 11 Körbling M, Fliedner TM, Calvo W, et al. Albumin density gradient purification of canine hemopoietic blood stem cells (HBSC): Long-term allogeneic engraftment without GVH-reaction. Exp Hematol 1979 ; 7: 277–288.
12. 12 Gerhartz HH, Nothdurft W, Carbonell F, Fliedner TM. Allogeneic transplantation of blood stem cells concentrated by density gradients. Exp Hematol 1985 ; 13: 136–142.
13. 13 Storb R, Epstein RB, Ragde H, Thomas ED. Marrow engraftment by allogeneic leukocytes in lethally irradiated dogs. Blood 1967 ; 30: 805–811.
14. 14 Buckner D, Eisel R, Perry S. Blood cell separation in the dog by continuous flow centrifugation. Blood 1968 ; 31: 653–672.
15. 15 Epstein RB, Clift RA, Thomas ED. The effect of leukocyte transfusions on experimental bacteremia in the dog. Blood 1969 ; 34: 782–790.
16. 16 Herbst EW, Fliedner TM, Calvo W, et al. Collection of hematopoietic stem cells from canine peripheral blood and their ability to regenerate hematopoiesis [German]. Blut 1975 ; 30: 265–276.
17. 17 Zander AR, Gray KN, Ben‐Ze'ev A, et al. Rescue by peripheral blood mononuclear cells in dogs from bone marrow failure after total‐body irradiation. Transfusion 1984 ; 24: 42–45.
18. 18 Ladiges WC, Storb R, Graham T, Thomas ED. Experimental techniques used to study the immune system of dogs and other large animals. In: Gay WI, Heavener JE, eds. Methods of Animal Experimentation, Vol. 7, Part C. New York: Academic Press ; 1989: 103–133.
19. 19 Lee R, Storb R, Little M‐T, et al. Percutaneous central dual‐lumen catheter for apheresis in the canine. J Invest Surg 2002 ; 15: 337–341.
20. 20 Storb R, Epstein RB, Thomas ED. Marrow repopulating ability of peripheral blood cells compared to thoracic duct cells. Blood 1968 ; 32: 662–667.
21. 21 Appelbaum FR. Hemopoietic reconstitution following autologous bone marrow and peripheral blood mononuclear cell infusions. Exp Hematol 1979 ; 7 (Suppl 5): 7–11.
22. 22 Sullivan RD, Stecher G, Sternberg SS. Value of bone marrow and spleen cell suspensions for survival of lethally irradiated dogs. J Natl Cancer Inst 1959 ; 23: 367–383.
23. 23 Appelbaum FR, Herzig GP, Graw RG, et al. Study of cell dose and storage time on engraftment of cryopreserved autologous bone marrow in a canine model. Transplantation 1978 ; 26: 245–248.
24. 24 Bodenberger U, Kolb HJ, Rieder I, et al. Fractionated total body irradiation and autologous bone marrow transplantation in dogs: Hemopoietic recovery after various marrow cell doses. Exp Hematol 1980 ; 8: 384–394.
25. 25 Van Bekkum DW, De Vries MJ. Radiation Chimaeras. London: Logos Press Limited ; 1967.
26. 26 Storb R, Epstein RB, Rudolph RH, Thomas ED. Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation 1969 ; 7: 378–386.
27. 27 Epstein RB, Storb R, Clift RA, Thomas ED. Autologous bone marrow grafts in dogs treated with lethal doses of cyclophosphamide. Cancer Res 1969 ; 29: 1072–1075.
28. 28 Thomas ED, LeBlond R, Graham T, Storb R. Marrow infusions in dogs given midlethal or lethal irradiation. Radiat Res 1970 ; 41: 113–124.
29. 29 Storb R, Weiden PL, Graham TC, et al. Hemopoietic grafts between DLA‐identical canine littermates following dimethyl myleran. Evidence for resistance to grafts not associated with DLA and abrogated by antithymocyte serum. Transplantation 1977 ; 24: 349–357.
30. 30 Storb R, Raff RF, Appelbaum FR, et al. What radiation dose for DLA‐identical canine marrow grafts? Blood 1988 ; 72: 1300–1304.
31. 31 Deeg HJ, Storb R, Longton G, et al. Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: Effects of exposure rate, fraction size and fractionation interval on acute and delayed toxicity. Int J Radiat Oncol Biol Phys 1988 ; 15: 647–653.
32. 32 Storb R, Raff RF, Appelbaum FR, et al. Comparison of fractionated to single‐dose total body irradiation in conditioning canine littermates for DLA‐identical marrow grafts. Blood 1989 ; 74: 1139–1143.
33. 33 Appelbaum FR, Brown P, Sandmaier B, et al. Antibody‐radionuclide conjugates as part of a myeloblative preparative regimen for marrow transplantation. Blood 1989 ; 73: 2202–2208.
34. 34 Bethge WA, Wilbur DS, Storb R, et al. Selective T‐cell ablation with bismuth‐213‐labeled anti‐TCRαβ as nonmyeloablative conditioning for allogeneic canine marrow transplantation. Blood 2003 ; 101: 5068–5075.
35. 35 Storb R, Thomas ED. Graft‐versus‐host disease in dog and man: The Seattle experience (Review). Immunol Rev 1985 ; 88: 215–238.
36. 36 Storb R, Kolb HJ, Deeg HJ, et al. Prevention of graft‐versus‐host disease by immunosuppressive agents after transplantation of DLA‐nonidentical canine marrow. Bone Marrow Transplant 1986 ; 1: 167–177.
37. 37 Thomas ED. Transplantation of hematopoietic progenitor cells with emphasis on the results in children. Turkish J Pediatr 1995 ; 37: 31–43.
38. 38 Kuhr CS, Lupu M, Little M‐T, et al. RDP58 does not prevent graft‐versus‐host disease after dog leukocyte antigen‐nonidentical canine hematopoietic cell transplantation. Transplantation 2006 ; 81: 1460–1462.
39. 39 Lupu M, McCune JS, Kuhr CS, Gooley T, Storb R, et al. Pharmacokinetics of oral mycophenolate mofetil in dog: Bioavailability studies and the impact of antibiotic therapy (Letter to the Editor). Biol Blood Marrow Transplant 2006 ; 12: 1352–1354.
40. 40 Epstein RB, Graham TC, Storb R, Thomas ED. Studies of marrow transplantation, chemotherapy and cross‐circulation in canine lymphosarcoma. Blood 1971 ; 37: 349–359.
41. 41 Weiden PL, Storb R, Lerner KG, et al. Treatment of canine malignancies by 1200 R total body irradiation and autologous marrow grafts. Exp Hematol 1975 ; 3: 124–134.
42. 42 Weiden PL, Storb R, Shulman H, Graham TC. Dimethyl myleran and autologous marrow grafting for the treatment of spontaneous canine lymphoma. Eur J Cancer Clin Oncol 1977 ; 13: 1411–1415.
43. 43 Weiden PL, Storb R, Sale GE, et al. Allogeneic hematopoietic grafts after total‐body irradiation in dogs with spontaneous tumors. J Natl Cancer Inst 1978 ; 61: 353–357.
44. 44 Weiden PL, Storb R, Deeg HJ, et al. Prolonged disease‐free survival in dogs with lymphoma after total‐body irradiation and autologous marrow transplantation consolidation of combination‐chemotherapy‐induced remissions. Blood 1979 ; 54: 1039–1049.
45. 45 Weiden PL, Storb R, Deeg HJ, Graham TC. Total body irradiation and autologous marrow transplantation as consolidation therapy for spontaneous canine lymphoma in remission. Exp Hematol 1979 ; 7 (Suppl 5): 160–163.
46. 46 Deeg HJ, Appelbaum FR, Weiden PL, et al. Autologous marrow transplantation as consolidation therapy for canine lymphoma: Efficacy and toxicity of various regimens of total body irradiation. Am J Vet Res 1985 ; 46: 2016–2018.
47. 47 Appelbaum FR, Deeg HJ, Storb R, et al. Marrow transplant studies in dogs with malignant lymphoma. Transplantation 1985 ; 39: 499–504.
48. 48 Appelbaum FR, Deeg HJ, Storb R, et al. Cure of malignant lymphoma in dogs with peripheral blood stem cell transplantation. Transplantation 1986 ; 42: 19–22.
49. 49 Goodman JW, Hodgson GS. Evidence for stem cells in the peripheral blood of mice. Blood 1962 ; 19: 702–714.
50. 50 McCredie KB, Hersh EM, Freireich EJ. Cells capable of colony formation in the peripheral blood of man. Science 1971 ; 171: 293–294.
51. 51 Debelak‐Fehir KM, Catchatourian R, Epstein RB. Hemopoietic colony forming units in fresh and cryopreserved peripheral blood cells of canines and man. Exp Hematol 1975 ; 3: 109–116.
52. 52 Storb R, Graham TC, Epstein RB, et al. Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 1977 ; 50: 537–542.
53. 53 Debelak‐Fehir KM, Epstein RB. Restoration of hematopoiesis in dogs by infusion of cryopreserved autologous peripheral white cells following busulfan‐cyclophosphamide treatment. Transplantation 1975 ; 20: 63–67.
54. 54 McSweeney PA, Rouleau KA, Wallace PM, et al. Characterization of monoclonal antibodies that recognize canine CD34. Blood 1998 ; 91: 1977–1986.
55. 55 McLeod BC, Price TH, Weinstein R. Apheresis: Principles and Practice. Bethesda, MD: AABB Press ; 2003.
56. 56 Lupu M, Sullivan EW, Westfall TE, et al. Use of multigeneration‐family molecular dog leukocyte antigen typing to select a hematopoietic cell transplant donor for a dog with T‐cell lymphoma. J Am Vet Med Assoc 2006 ; 228: 728–732.
57. 57 Eckstein R, Weisbach V, Zeiler T, et al. Stem cell separation with different cell separators [German]. Beitrage zur Infusionstherapie 1991 ; 28: 247–250.
58. 58 Galacki DM. An overview of therapeutic apheresis in pediatrics (Review). J Clin Apher 1997 ; 12: 1–3.
59. 59 Zaucha JM, Zellmer E, Georges G, et al. G‐CSF‐mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required. Biol Blood Marrow Transplant 2001 ; 7: 613–619.
60. 60 Martin PJ. The role of donor lymphoid cells in allogeneic marrow engraftment. Bone Marrow Transplant 1990 ; 6: 283–289.
61. 61 Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral‐blood cells from HLA‐identical relatives in patients with hematologic cancers. N Engl J Med 2001 ; 344: 175–181.
62. 62 Bolan CD, Cecco SA, Wesley RA, et al. Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation. Transfusion 2002 ; 42: 935–946.
63. 63 Murata M, Harada M, Kato S, et al. Peripheral blood stem cell mobilization and apheresis: Analysis of adverse events in 94 normal donors. Bone Marrow Transplant 1999 ; 24: 1065–1071.
64. 64 Falzetti F, Aversa F, Minelli O, Tablio A. Spontaneous rupture of spleen during peripheral blood stem‐cell mobilization in a healthy donor (Research Letter). Lancet 1999 ; 353: 555.
65. 65 Becker PS, Wagle M, Matous S, et al. Spontaneous splenic rupture following administration of granulocyte colony‐stimulating factor (G‐CSF): Occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplantation 1997 ; 3: 45–49.
66. 66 McGee DC, Gould MK. Preventing complications of central venous catheterization (Review). N Engl J Med 2003 ; 348: 1123–1133.
67. 67 Matus RE, Leifer CE, Gordon BR, et al. Plasmapheresis and chemotherapy of hyperviscosity syndrome associated with monoclonal gammopathy in the dog. J Am Vet Med Assoc 1983 ; 183: 215–218.
68. 68 Dennis MB Jr, Schmer G, Rastelli LN, et al. Successful long‐term use of a plasmapheresis reactor system in dogs with lymphoma. Trans Am Soc Artif Intern Organs 1983 ; 39: 744–748.